| Factor Information | |
|---|---|
| Data ID | 572 |
| Factor | minor complications with younger patients |
| Description | Vascular complications were frequent among younger patients, with prolonged procedure time and vessel access (p<0.0001). Most frequent minor complications were vascular complications (45.2%) All vascular (both minor and major) complications were more frequent among younger patients, especially when the time to access vessel and the duration of the procedure were prolonged. |
| Biomarker | NA |
| Classification | E1 (physiological factor - age) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Vascular complications, prolonged procedure time and vessel access |
| p Value | <0.0001 |
| Conclusion | The most frequent adverse events in general are vascular complications, whereas events related to anesthesia and airway management seem to be among the most frequent major complications. Cardiac interventions, especially balloon dilatation procedures, catheterizations in cyanotic patients or newborns carry the highest risk. Awareness of complications, improved intensive care, improvement in technique and equipment will decrease or avoid the incidence of complications |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 470 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
| Reference | |
|---|---|
| PMID | 13653204 |
| Year | 2018 |
| Title | Complications of cardiac catheterization in children with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Newborn (1-30days) Infant (1 month-1 year) Child (1-12 years) Adolescent (12-21 years) | |
| Source | Data | |
| Region | İstanbul, Turkey | |
| Method | retrospectively study | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac catheterizations | |
| Group | minor complications(Treatment) | without complications(Control) |
| Number | N/A | N/A |
| Age | mean age: 20.5±48.1 months (minor complications) | mean age: 62.3±65.3 months (without complications) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | mean age: 20.5±48.1 months | mean age: 62.3±65.3 months |
